ARTICLE | Clinical News
Amiscan: Phase I testing update
May 15, 2000 7:00 AM UTC
Draxis Health Inc. (DRAX; TSE:DAX), Mississauga, Ontario Product: Amiscan Business: Diagnostics/Imaging Therapeutic category: Imaging agent Target: NA Description: Technetium-labeled D-glucaric acid ...